NASDAQ
No price data available for this timeframe.
Gossamer Bio, Inc. (GOSS) has a free cash flow growth of 19.86% as of Friday, May 29, 2026. This represents a 294.15% increase compared to its 12-month average of -10.23%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.